At ProtTech Inc., our mission is to develop innovative protein-related technologies, services and products to support life science research, diagnostics and drug development. We provide services for protein identification, analyzing protein modifications and mutations, de novo sequencing of antibodies, and characterization of therapeutic proteins. We provide protein products including mRNA vaccine enzymes, cytokins, tool enzymes, and mab reagents. We also provide proprietary platform technologies for the discovery of cancer vaccines and develop therapeutic fusion proteins to increase the in vivo half-life of signaling molecules and/or nanobodies.